Nymirum
Joshua (JP) is a co-founder and CEO of Nymirum and has sat at the intersection of entrepreneurship and investments for two decades. Prior to Nymirum, he co-founded and took public Akebia (NASDAQ: AKBA), a biotech in kidney disease and Aerpio (NASDAQ: ARPO), a biotech in ocular diseases. He was also the Founding Partner of Orchard Venture Partners (a biotech VC fund) and of Orchard Capital Management.
Fairbank is also an Adjunct Assistant Professor of Entrepreneurship at the University of Chicago Booth School of business. He received his MBA from Chicago Booth and his BA in Economics from Connecticut College.
Nymirum
Nymirum exploits the dynamics and atomic-scale structure of RNA to guide novel small molecule drug discovery.